NT5E and neoplasm: This study identifies CD73 (NT5E) as a direct hypoxia-responsive effector of HIF1α and demonstrates that dual inhibition of HIF1α and CD73 synergistically suppresses tumor cell viability, disrupts adenosine metabolism, and impairs angiogenic and migratory signaling.